Top

Outcomes of chronic neutrophilic leukemia patients who underwent allogeneic hematopoietic cell transplantation: a combined CIBMTR/EBMT analysis

Study type:

Study number:

42201064

Type of treatment:

Allogeneic

Diseases:

Myeloproliferative Neoplasm (MPN)

Short title:

Primary objective:

Analyze outcomes of CNL patients who underwent allo-HCT

Key inclusion criteria:

- Adult patients (ages ≥18 years) who underwent first allo-HCT through 2018
- Diagnosis of CNL

Country:

Principal investigator:

Bhagirathbai Dholaria/Aleksandar Radujkovic

EBMT Study coordinator:

Linda Koster

Study coordinator email:

cmwpebmt@lumc.nl